STGen Bio announced on the 14th that its Songdo Bio Plant has received current Good Manufacturing Practice (cGMP) approval from the U.S. Food and Drug Administration (FDA). The approval covers the…

Hugel has won the final ruling in the botulinum toxin-related lawsuit it faced against Medytox in the United States International Trade Commission (ITC). The ruling clears Hugel of allegations that it…

Liga-Chem Biosciences announced on the 10th that it had signed two licensing agreements with Ono Pharmaceutical, a leading pharmaceutical company in Japan. The pipeline that Liga-Chem…

Orum Therapeutics, a biotechnology company preparing for its KOSDAQ listing, announced its goal to achieve sales of KRW 93 billion (USD 69.9 million) by 2026. In a media conference call held on the…

There is an evaluation that Samsung Biologics' stock could rise in the short term if the U.S. Biosecurity Law is passed. On the 7th, Kim Jun-young of Meritz Securities stated, “Samsung Biologics is a…

Celltrion has officially entered the ASEAN market by establishing a local subsidiary in Vietnam. Following the company's tradition of having its top executives spearhead entry into key markets,…

Celltrion announced on the 27th that it has launched a media campaign in the U.S. for "Zymfentra," the world’s only infliximab subcutaneous (SC) formulation for treating autoimmune diseases. The…

HK inno.N's novel drug for gastroesophageal reflux disease (GERD), K-CAB, has received marketing approval in Malaysia. HK inno.N announced on the 26th that K-CAB tablets (ingredient: Tegoprazan) were…

Samsung Biologics announced on the 25th that it has introduced two new Contract Development Organization (CDO) platforms at the ‘2024 Bio Process International (BPI)’ conference, a global bio…

The government has selected the ‘Korea Value Up’ Index as part of its efforts to address the Korea Discount, and 12 stocks from the healthcare sector have been included in the index. On the 24th,…